Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1 1

Status

Recruiting 25Active not recruiting 19Completed 18Not yet recruiting 5Terminated 3Withdrawn 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 3NIH 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Melanoma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia 1Hepatitis 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Colitis 1Advanced Glioblastoma 1

Interventions

Specimen Handling 76Cisplatin 64Drug Therapy 63Carboplatin 63Bevacizumab 63Magnetic Resonance Spectroscopy 59Radiotherapy 57Gemcitabine 54Cyclophosphamide 54pembrolizumab 52Oxaliplatin 49Capecitabine 49toripalimab 44Paclitaxel 40tislelizumab 39Standard of Care 39fludarabine 36Injections 34Fluorouracil 34Biopsy 34venetoclax 33Blood Specimen Collection 31Immune Checkpoint Inhibitors 30anlotinib 28Nivolumab 28Surgical Procedures, Operative 27Irinotecan 27Docetaxel 27Leucovorin 26Dexamethasone 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Mycophenolic Acid × 1 year × Clear all
NCT07524530 2026-06-05

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Not yet recruiting
98 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Hematologic Neoplasms

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

NCT07548983 2026-04-23

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

OHSU Knight Cancer Institute

Phase 1 Not yet recruiting
40 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07349771 2026-04-16

Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Mayo Clinic

Phase 2 Not yet recruiting
72 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡